MCM Group
Molecular and Cellular Modeling

News

EuroNeurotrophin project starts

1. March 2018

14 Early Stage Researchers to be trained in a European training network for the discovery of small molecule neurotrophin mimetics as candidate …

Read more

A matter of mobility: multidisciplinary paper suggests new strategy for drug discovery

15. January 2018

A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The …

Read more

Announcing Fourth Biological Diffusion and Brownian Dynamics Brainstorm Meeting (BDBDB 4)

11. October 2017

Biological Diffusion and Brownian Dynamics Brainstorm 4 (BDBDB4) will, like the previous meetings (the last was BDBDB3), provide a forum for intensive …

Read more

New TRAPP webserver for studying TRAnsient Pockets in Proteins

29. May 2017

Many drugs exert their therapeutic effects by binding in cavities or pockets on specific target protein macromolecules. The binding pockets on …

Read more

Young Researcher´s award goes to HITS doctoral student

17. May 2017

Mehmet Ali Öztürk, PhD student at HITS and at the Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology (…

Read more

On the front cover: Multiexpert Platform for the Identification of Hits Targeting Parasitic Enzymes

29. March 2017

In the New Medicines for Trypanosomatidic Infections (NMTRypI) project funded by the EU and completed in January 2017, in which 13 partners …

Read more

HITS is New Associate Partner of CompBioMed Project

28. October 2016

Heidelberg Institute for Theoretical Studies (HITS), represented by its Molecular and Cellular Modeling Group (MCM), led by Professor Rebecca Wade, has …

Read more

On YouTube: Dr. Kashif Sadiq’s talk on “Predictive Synthetic Retrovirology” at European Health Science Match 2016

24. October 2016

Dr. Kashif Sadiq from Molecular and Cellular Modeling (MCM) group at HITS was one of the 100 speakers selected for the European …

Read more

Switch to the German homepage or stay on this page